Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2026
상품코드:1939254
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
체외진단(IVD)용 인공지능(AI) 시장에서 인공지능(AI) 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 30억 4,000만 달러에서 2026년에는 36억 달러로, CAGR 18.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 정확한 진단에 대한 수요 증가, 검사실 인프라 확충, 만성질환 유병률 증가, 디지털 진단 툴의 도입, 바이오마커 연구의 발전 등이 주요 요인으로 꼽힙니다.
체외진단(IVD)용 인공지능(AI) 시장에서 인공지능(AI) 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 70억 1,000만 달러에 달하며, CAGR은 18.1%에 달할 전망입니다. 예측 기간의 성장 요인으로는 클라우드 기반 진단 플랫폼의 확대, AI와 유전체학의 통합, POC(Point-Of-Care) AI 진단의 개발, 맞춤형 의료에 대한 투자 증가, 신속하고 비용 효율적인 검사에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향에는 AI를 활용한 검사실 자동화, 예측적 질병 진단, 데이터베이스 검사 결과 해석, 클라우드 기반 진단 플랫폼, 개인화된 환자 프로파일링 등이 포함됩니다.
맞춤형 의료에 대한 수요 증가는 체외진단용 의약품(IVD) 시장에서 인공지능(AI)의 확장을 촉진할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전자 프로파일, 생활습관, 환경에 따라 예방, 진단, 치료를 맞춤화하는 것을 말합니다. 맞춤형 의료의 보급 확대는 보다 정밀하고 효과적이며 표적화된 치료를 가능하게 하는 유전체 데이터와 시퀀싱 기술의 발전에 힘입은 바 큽니다. IVD에서 AI는 복잡한 진단 데이터를 분석하여 환자별 고유한 질병 패턴을 파악하고, 의료진이 적시에 정확한 치료 결정을 내릴 수 있도록 돕는 중요한 역할을 합니다. 예를 들어 맞춤형 의료연합(PMC)의 보고에 따르면 2024년 2월 현재 FDA는 2023년 희귀질환에 대한 16건의 새로운 개인맞춤형 치료제를 승인했습니다. 이는 2022년 6건에서 크게 증가한 수치입니다. 세부적으로는 암치료제7건, 기타 질환 치료제 3건입니다. 이처럼 맞춤형 의료에 대한 수요 증가가 IVD 분야 AI의 성장을 촉진하고 있습니다.
IVD 분야 AI 시장을 선도하는 기업은 진단 정확도 향상, 워크플로우 효율화, 맞춤형 의료 지원을 위한 첨단 솔루션 개발에 집중하고 있습니다. 구체적으로는 CE-IVDR 인증을 획득한 투명한 AI 플랫폼 개발을 들 수 있습니다. 이는 EU 규제 기준을 충족하고 명확하고 감사 가능한 의사결정 프로세스를 제공하는 AI 시스템입니다. 2025년 5월, 영국에 본사를 둔 진단 검사 기업 Diagnostics.ai는 PCR 진단의 신속성과 정확도 향상을 목표로 하는 첨단 솔루션 'PCR.AI'를 발표했습니다. 이 플랫폼은 실시간 PCR 결과 해석을 99.9% 이상의 정확도로 자동화하고, 각 결과 도출 과정을 명확하게 표시하여 투명성을 제공합니다. 이 기능은 규제 준수를 보장하고 임상 현장의 신뢰성을 향상시킵니다. 또한 실험실의 효율성을 크게 향상시키고, 오류를 줄이며, 분자진단의 원활한 규정 준수를 지원합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data obtained from laboratory tests on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.
The primary components of AI in in vitro diagnostics include software, hardware, and services. Software consists of programs and data that instruct a computer to perform specific tasks. It leverages technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and can be deployed through cloud-based, on-premise, or hybrid methods. Applications include diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. Primary end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.
Tariffs are impacting the ai in vitro diagnostics market by increasing costs of importing laboratory instruments, diagnostic software, and biomarker testing kits, particularly in asia-pacific and european regions. Hardware-heavy segments like laboratory instruments and imaging devices are most impacted, causing delays and higher operational costs for diagnostic laboratories. On the positive side, tariffs are driving local production and innovation, leading to more cost-efficient ai-based diagnostic solutions and regional manufacturing capabilities.
The artificial intelligence (AI) in in vitro diagnostics (ivd) market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics (ivd) market statistics, including artificial intelligence (AI) in in vitro diagnostics (ivd) industry global market size, regional shares, competitors with a artificial intelligence (AI) in in vitro diagnostics (ivd) market share, detailed artificial intelligence (AI) in in vitro diagnostics (ivd) market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in in vitro diagnostics (ivd) industry. This artificial intelligence (AI) in in vitro diagnostics (ivd) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (ai) in in vitro diagnostics (ivd) market size has grown rapidly in recent years. It will grow from $3.04 billion in 2025 to $3.6 billion in 2026 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historic period can be attributed to rising demand for accurate diagnostics, growth of laboratory infrastructure, increasing prevalence of chronic diseases, adoption of digital diagnostic tools, advancements in biomarker research.
The artificial intelligence (ai) in in vitro diagnostics (ivd) market size is expected to see rapid growth in the next few years. It will grow to $7.01 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to expansion of cloud-based diagnostic platforms, integration of ai with genomics, development of point-of-care ai diagnostics, growing investments in personalized medicine, increasing demand for rapid and cost-effective testing. Major trends in the forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, cloud-based diagnostic platforms, personalized patient profiling.
The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is largely fueled by advancements in genomic data and sequencing technologies, which allow for more precise, effective, and targeted treatments. AI in IVD plays a vital role by analyzing complex diagnostic data to identify disease patterns specific to each patient, helping healthcare providers make timely and accurate treatment decisions. For example, the Personalized Medicine Coalition reported that in February 2024, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. This includes seven cancer drugs and three treatments for other conditions. The rising demand for personalized medicine is thus driving the growth of AI in IVD.
Companies in the AI in IVD market are focused on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system that meets EU regulatory standards, providing clear, auditable decision-making. In May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an advanced solution designed to speed up and improve PCR diagnostics. This platform automates real-time PCR result interpretation with over 99.9% accuracy, offering transparency by clearly displaying how each result is derived. This feature ensures regulatory compliance and enhances clinical trust. It also significantly boosts laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.
In April 2025, bioMerieux SA, a France-based company specializing in AI for IVD, partnered with Mila, a Canadian AI research institute, to advance research and innovation in AI-driven diagnostics and antibiotic resistance detection. The collaboration aims to create cutting-edge AI solutions that enhance the accuracy and efficiency of IVD tools, with a particular focus on improving the detection of antibiotic resistance. Mila is renowned for its pioneering work in machine learning and AI research.
Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Component: Software; Hardware; Services
2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
Subsegments:
1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
4.1.3 Biotechnology, Genomics & Precision Medicine
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
4.2.1 Ai-Enabled Laboratory Automation
4.2.2 Predictive Disease Diagnostics
4.2.3 Data-Driven Test Interpretation
4.2.4 Cloud-Based Diagnostic Platforms
4.2.5 Personalized Patient Profiling
5. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Analysis Of End Use Industries
5.1 Hospitals And Clinics
5.2 Diagnostic Laboratories
5.3 Research Institutes
5.4 Pharmaceutical Companies
5.5 Medical Device Manufacturers
6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Size, Comparisons And Growth Rate Analysis
7.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation
9.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Software, Hardware, Services
9.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
9.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cloud-Based, On-Premise, Hybrid
9.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
9.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
9.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
9.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Consulting And Implementation, Maintenance And Support, Training And Education
10. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis
10.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
11.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
12.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
13.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
14.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
15.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
16.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
17.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
18.1. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
19.1. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
20.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
21.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
22.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
23.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
24.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
25.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
26.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
27.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
28.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
29.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
30.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
31.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
32.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
33.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market
34.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regulatory and Investment Landscape
36. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles
36.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
36.3.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
37. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies
